Citations 1
Effect of the addition of temsirolimus to cetuximab in cetuximab-resistant head and neck cancers: Results of the randomized PII MAESTRO study.
Chawla, Apoorva, Hu, H. Shawn, Price, Katharine A. , Zavala, Jose D, Karrison, Theodore , Villaflor, Victoria , Adkins, Douglas R. , Worden, Francis P. , Rao, Krishna A , Zavala, Jose D, Stadler, Walter M. , Lussier, Yves A. , Vokes, Everett E. , Cohen, Ezra E.W. , Seiwert, Tanguy Y.
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 6089-6089
